ArticleMolecular biotechnology2026
The Application of Reverse Transcription Loop-mediated Isothermal Amplification to Detect Cell-Free Seminal mRNA.
Article in Molecular biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cell-free seminal mRNA (cfs-mRNA) has been utilized in the diagnosis of diseases affecting the male reproductive system. However, the existing detection methods are time-consuming and labor-intensive. Loop-mediated isothermal amplification (LAMP) is a nucleic acid amplification method with high efficiency and accuracy; however, it has not been applied to cell-free RNA in human body fluids. Herein, we designed gene-specific primers for TGM4 and DDX4 and established a reverse transcription-LAMP (RT-LAMP) system for detecting their cfs-mRNA. The sensitivity of this system was investigated using RNA standards. The optimal conditions were 65 ℃ for 30 to 45 min for TGM4 and 65 ℃ for 45 to 60 min for DDX4. When incubated at 65 ℃ for 45 min, the limit of detection (LOD) for DDX4 mRNA was 124 copies, which increased to 37 copies when the reaction time was extended to 90 min. We also validated the RT-LAMP reaction using semen plasma samples from 20 azoospermic patients and identified 3 DDX4 cfs-mRNA negative patients among 72 azoospermic patients in total. In conclusion, this study establishes a novel RT-LAMP method for rapid and sensitive detection of TGM4 and DDX4 cfs-mRNA in seminal plasma. RT-LAMP is a rapid, sensitive and specific method for cfs-mRNA detection, which has the potential to be used in the diagnosis of male reproductive system diseases, RNA detection in other body fluids, and commercial promotion. The validated technique offers significant potential for efficient diagnosis of male reproductive disorders and broader RNA detection applications.
Indexed as
Identifiers
41082003What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.